Samsung’s AI lab in Montreal new Tiny Recursive Model with only 7M parameters performs as well, if not better in some ...
Recursion Pharmaceuticals jumped by 16.44 percent on Wednesday to close at $6.09 apiece as investors repositioned portfolios ahead of expected updates from an upcoming AI conference in Dubai.
Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 ...
TipRanks on MSN
Recursion Pharmaceuticals rises 17.9%
Recursion Pharmaceuticals (RXRX) is up 17.9%, or 93c to $6.17. Published first on TheFly – the ultimate source for real-time, market-moving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback